Prescription Drug Monitoring Programs
"Prescription Drug Monitoring Programs" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Programs, usually run by state governments, that require pharmacists to collect and distribute data on the prescription and dispensation of CONTROLLED SUBSTANCES. They are intended to prevent the abuse of such substances by the patient, or their transfer to recreational users and drug dealers.
Descriptor ID |
D000073958
|
MeSH Number(s) |
E05.337.800.800 N02.421.668.320.600
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Prescription Drug Monitoring Programs".
Below are MeSH descriptors whose meaning is more specific than "Prescription Drug Monitoring Programs".
This graph shows the total number of publications written about "Prescription Drug Monitoring Programs" by people in this website by year, and whether "Prescription Drug Monitoring Programs" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2017 | 2 | 0 | 2 |
2018 | 0 | 1 | 1 |
2020 | 0 | 1 | 1 |
2021 | 2 | 0 | 2 |
2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Prescription Drug Monitoring Programs" by people in Profiles.
-
Discrepancies Between the Electronic Medical Record and Website Access to the Prescription Drug Monitoring Program. J Pain Symptom Manage. 2024 Mar; 67(3):e251-e253.
-
Association of cash payment with intensity of opioid prescriptions. J Am Pharm Assoc (2003). 2022 Jul-Aug; 62(4):1224-1231.e5.
-
Improving Opioid Stewardship in Pediatric Emergency Medicine. Pediatrics. 2021 12 01; 148(6).
-
Factors associated with the use of the prescription monitoring program by prescribers and pharmacists in Texas. Pharmacoepidemiol Drug Saf. 2021 04; 30(4):492-503.
-
Deficiencies with the Use of Prescription Drug Monitoring Program in Cancer Pain Management: A Report of Two Cases. J Palliat Med. 2021 05; 24(5):751-754.
-
Development of a health communication campaign to promote the Texas prescription monitoring program. Health Mark Q. 2020 Jul-Sep; 37(3):222-231.
-
Impact of COVID-19 related policy changes on filling of opioid and benzodiazepine medications. Res Social Adm Pharm. 2021 01; 17(1):2005-2008.
-
Using the theory of planned behavior to investigate community pharmacists' beliefs regarding engaging patients about prescription drug misuse. Res Social Adm Pharm. 2019 08; 15(8):992-999.
-
Prescribers' perceptions on the impact of hydrocodone rescheduling on geriatric pain management: A qualitative study. J Opioid Manag. 2018 Sep/Oct; 14(5):317-326.
-
Prevalence and Factors Associated with Multiple Provider Episodes in Texas: An Epidemiological Analysis of Prescription Drug Monitoring Program Data. Pain Med. 2017 Oct 01; 18(10):1941-1951.